动态前哨淋巴结活检在cN0阴茎癌腹股沟淋巴结分期中的准确性
该回顾性研究纳入75例cN0阴茎癌患者共77例次动态前哨淋巴结活检(DSNB),评估前哨淋巴结显像特征与结局指标。DSNB检出率91%(每例次)和96%(每侧腹股沟),敏感度79%、特异度100%、阴性预测值97%、阳性预测值100%。仅1例(1%)发生DSNB相关不良事件,结论认为DSNB安全且阴性预测值高。
要点
- DSNB每例次检出率91%、每侧腹股沟96%,敏感度79%、特异度100%、NPV 97%、PPV 100%。
- SPECT/CT较静态平面显像见更多前哨淋巴结(1.33 vs 1.17,p=0.001)。
- 75例中仅1例(1%)发生DSNB相关不良事件。
核心结论
- DSNB是安全诊断方法,检出率好且阴性预测值尤其高。
- DSNB可避免临床检查和DSNB检查均阴性患者过度治疗。
- DSNB能早期发现标准影像无法显示的隐匿转移。
研究设计与样本
- 回顾性纳入2015年1月至2021年5月本中心转诊行DSNB、无腹股沟淋巴结转移且随访至少18个月的阴茎癌患者。
- 共纳入75例患者(67±11岁)的77例次阴茎DSNB操作。
- 每例患者瘤周注射85±20 MBq [99mTc]Tc-纳米胶体后行动态、静态平面及SPECT/CT显像。
主要发现
- DSNB检出率每例次91%、每侧腹股沟96%。
- 敏感度79%、特异度100%、阴性预测值97%、阳性预测值100%。
- SPECT/CT见前哨淋巴结数多于静态平面显像(1.33 vs 1.17,p=0.001)。
- 静态平面显像每枚前哨淋巴结平均计数低于SPECT/CT(1343 vs 5008,p<0.0001)。
- 静态平面与SPECT/CT前哨淋巴结总计数呈正相关(r=0.79,p<0.0001)。
关键数值与推荐
- 75例中1例(1%)发生DSNB相关不良事件。
- 18个月后58例(77%)无病生存,13例(17%)局部复发,4例(5%)发生淋巴或远处转移。
临床怎么用
- 原文结论认为DSNB安全、检出率好且阴性预测值高,可避免临床检查和DSNB均阴性患者的过度治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Penile cancer is characterized by an early lymphatic dissemination. In intermediate and high-risk primary tumors without palpable inguinal lymph nodes, there is a 6-30% risk of micro-metastatic disease. Invasive lymph node staging in these patients is performed using dynamic sentinel lymph node biopsy (DSNB). In this study, the role of DSNB in cN0 penile cancer was studied, evaluating features of sentinel lymph node (SN) visualization and outcome parameters. Patients with penile cancer without inguinal lymph node metastases who were referred for DSNB at our center between January 2015 and May 2021 and had a follow-up period of at least 18 months, were retrospectively included. After injection of 85 ± 20 MBq [99mTc]Tc-nanocolloid peritumorally, dynamic, static planar and SPECT/CT imaging was performed. Primary endpoints were sensitivity of the diagnostic procedure, disease-free survival and DSNB-related adverse events. Secondary endpoints were SN detection rate, number of SNs and the number of counts of the most active SN. RESULTS: Seventy-seven penile DSNB procedures in 75 patients (67 ± 11 years) were included. The detection rate of DSNB was 91% and 96% per procedure and groin, respectively. Sensitivity, specificity, negative predictive value (NPV) and positive predictive value (PPV) were 79%, 100%, 97% and 100%, respectively. More SNs were seen on SPECT/CT than on static planar imaging (1.33 vs. 1.17, p = 0.001). The mean counts per SN on static planar imaging was lower compared to SPECT/CT (1343 vs. 5008; p < 0.0001). There was a positive correlation between the total counts of the SN on the static planar image and the SPECT/CT (r = 0.79, p < 0.0001). Only one out of seventy-five patients (1%) experienced DSNB-related adverse events. After 18 months, 58 patients remained disease free (77%), 13 developed local recurrence (17%), and 4 developed lymphatic or distant metastases (5%). CONCLUSION: DNSB is a safe diagnostic procedure with a good detection rate and in particular high negative predictive value. It can therefore prevent overtreatment of patients with negative inguinal groins on clinical examination and DSNB examination. Finally, DSNB enables an early detection of occult metastases which would not be visualized with standardized imaging modalities.
引用
- Gebruers J, Elst L, Baldewijns M, et al. Accuracy of dynamic sentinel lymph node biopsy for inguinal lymph node staging in cN0 penile cancer. EJNMMI Res. 2023. PMID: 37351700. doi:10.1186/s13550-023-01013-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。